0001183740-19-000039.txt : 20190322 0001183740-19-000039.hdr.sgml : 20190322 20190321202435 ACCESSION NUMBER: 0001183740-19-000039 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190322 DATE AS OF CHANGE: 20190321 EFFECTIVENESS DATE: 20190322 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CONCEPTION HOLDINGS, INC. CENTRAL INDEX KEY: 0001757785 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-331697 FILM NUMBER: 19698195 BUSINESS ADDRESS: STREET 1: 1500 - 1055 WEST GEORGIA ST CITY: VANCOUVER STATE: A1 ZIP: V6E 4N7 BUSINESS PHONE: 604-689-9111 MAIL ADDRESS: STREET 1: 1500 - 1055 WEST GEORGIA ST CITY: VANCOUVER STATE: A1 ZIP: V6E 4N7 D/A 1 primary_doc.xml X0708 D/A LIVE 0001757785 CONCEPTION HOLDINGS, INC. 1500 - 1055 WEST GEORGIA ST VANCOUVER A1 BRITISH COLUMBIA, CANADA V6E 4N7 604-689-9111 BRITISH COLUMBIA, CANADA None None Corporation true 2018 BRUCE DAVID VOSBURG 3 E 3RD AVENUE CALIFORNIA X1 UNITED STATES 94401 Executive Officer Director Promoter RALPH RISCH 3 E 3RD AVENUE CALIFORNIA X1 UNITED STATES 94401 Executive Officer Director Promoter KEVIN BROOKS 3 E 3RD AVENUE CALIFORNIA X1 UNITED STATES 94401 Executive Officer Director NISHAN KARASSIK 3 E 3RD AVENUE CALIFORNIA X1 UNITED STATES 94401 Promoter Director and executive officer of Phylos Bioscience, Inc., a promoter of the Issuer. SCOTT BOWMAN 3 E 3RD AVENUE CALIFORNIA X1 UNITED STATES 94401 Promoter Director and executive officer of Phylos Bioscience, Inc., a promoter of the Issuer. TIMOTHY GREGORY 3 E 3RD AVENUE CALIFORNIA X1 UNITED STATES 94401 Promoter Director of Phylos Bioscience, Inc., a promoter of the Issuer. SONIA LO 3 E 3RD AVENUE CALIFORNIA X1 UNITED STATES 94401 Promoter Director and executive officer of Crop One Alternative Medicine Licensing, LLC, a promoter of the Issuer. Other Decline to Disclose 06b true 0001183740-19-000020 2018-10-15 false true true true false 0 2832500 2832500 0 Total Offering Amount represents aggregate principal amount of 8% unsecured convertible debentures, convertible into common shares without further payment the earlier of completion of a qualified financing/36 months from the date of issuance. false 24 0 0 0 false CONCEPTION HOLDINGS, INC. /s/ Kevin Brooks Kevin Brooks CEO 2019-03-20